Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
unknown
📅 Published: 2026-02-11 10:00
📰 Source: SeekingAlpha
📝 Words: 25
📝 Article Content
All eyes should be on Bristol-Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.
📄 Summary
All eyes should be on Bristol-Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-02-12 12:07:58
Updated At:
2026-02-12 12:07:58
Scraping Job ID:
N/A
Stock Mentions:
BMY - [PLACEHOLDER] BMY
Relevance: N/A
ALL - The Allstate Corporation
Relevance: N/A